2025
Local definitive therapy (LDT) utilization patterns and outcomes in chromophobe renal cell carcinoma (chRCC) with metachronous metastasis: A multi-institution study.
Dizman N, Doshi S, Knezevic A, Feinaj A, Sayegh N, Hobeika C, Alaghehbandan R, Rives H, Zengin Z, Braun D, Zibelman M, McGregor B, Hammers H, Ged Y, Ornstein M, Msaouel P, Hahn A, Voss M. Local definitive therapy (LDT) utilization patterns and outcomes in chromophobe renal cell carcinoma (chRCC) with metachronous metastasis: A multi-institution study. Journal Of Clinical Oncology 2025, 43: 503-503. DOI: 10.1200/jco.2025.43.5_suppl.503.Peer-Reviewed Original ResearchLocal definitive therapySarcomatoid dedifferentiationMetachronous metastasesSystemic treatmentST cohortDuration of disease controlChromophobe renal cell carcinomaTreatment characteristics of patientsMetastatic disease diagnosisSingle-organ metastasisTreatment-free intervalTreatment-free survivalKaplan-Meier methodRenal cell carcinomaFisher's exact testCharacteristics of patientsMulti-institutional studyWilcoxon rank sum testRank sum testMetastatic sitesSurgical resectionDefinitive therapyRare subtypeMedian intervalCell carcinoma
2024
Long-term posttransplant-related bone volumetric changes in eight face transplant recipients – A single-center retrospective case series
Huelsboemer L, Boroumand S, Boroumand T, Vafa A, Parikh N, Chiarella L, Knoedler L, Stögner V, Hung P, Sadigh S, Haykal S, Pomahac B, Kauke-Navarro M. Long-term posttransplant-related bone volumetric changes in eight face transplant recipients – A single-center retrospective case series. Journal Of Plastic Reconstructive & Aesthetic Surgery 2024, 101: 220-230. PMID: 39848075, DOI: 10.1016/j.bjps.2024.11.025.Peer-Reviewed Original ResearchFacial vascularized composite allograftBone volume changesBone volumeChronic rejection processRetrospective case seriesComputed tomography scanBone volume lossWilcoxon rank sum testNative boneSignificant median decreaseBone volume stabilityRank sum testFace transplant recipientsBone remodeling ratesVascularized composite allograftsChronic immunosuppressionTooth lossTransplant recipientsAllograft cohortCase seriesTomography scanVolume lossMedian decreaseMedical comorbiditiesHistopathological analysisLongitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron
Karaba A, Xue J, Johnston T, Traut C, Dalrymple L, Kossmann R, Blankson J, Parikh C, Ray S. Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron. Kidney International Reports 2024, 10: 406-415. PMID: 39990910, PMCID: PMC11843127, DOI: 10.1016/j.ekir.2024.11.012.Peer-Reviewed Original ResearchT cell responsesT cellsHealthy controlsCOVID-19 vaccineAntibody responsePositive T-cell responsesResponse to COVID-19 vaccinationPaired Wilcoxon rank sum testSARS-CoV-2 immunityObservational multicenter cohortFisher's exact testDose of COVID-19 vaccineWilcoxon rank sum testVaccinated healthy controlsSevere COVID-19SARS-CoV-2 responseAnti-SARS-CoV-2 IgGRank sum testAnti-SARS-CoV-2Response to spikesTransmission-based precautionsMulticenter cohortSurrogate neutralizationExact testACE2 inhibitionEnhanced placental antibody transfer efficiency with longer interval between maternal RSV vaccination and birth
Jasset O, Lopez Zapana P, Bahadir Z, Shook L, Dennis M, Gilbert E, Liu Z, Yinger R, Bald C, Bradford C, Silfen A, Klein S, Pekosz A, Permar S, Konnikova L, Yonker L, Lauffenburger D, Nelson A, Elovitz M, Edlow A. Enhanced placental antibody transfer efficiency with longer interval between maternal RSV vaccination and birth. American Journal Of Obstetrics And Gynecology 2024 PMID: 39515450, DOI: 10.1016/j.ajog.2024.10.053.Peer-Reviewed Original ResearchMaternal RSV vaccineRespiratory syncytial virusRespiratory syncytial virus vaccineNatural RSV infectionRSV vaccineRSV infectionBinding antibody multiplex assayTiming of maternal vaccinationTransplacental transfer of maternal antibodiesAntibody levelsRespiratory syncytial virus strains A2Vaccine administrationInfant antibody levelsMaternal antibodiesMother to fetusProspective cohort studyTransfer of maternal antibodiesWilcoxon rank sum testWeek windowVaccination timingLevels of IgGRank sum testTransfer of antibodiesMonths of ageGestational ageToxicity and Efficacy of Isavuconazole Vs Voriconazole As Anti-Fungal Prophylaxis for Patients with Acute Myeloid Leukemia
Hunter C, Bewersdorf J, Mendez L, Podoltsev N, Zeidan A, Eighmy W, Roeder H, Malinis M, Shallis R. Toxicity and Efficacy of Isavuconazole Vs Voriconazole As Anti-Fungal Prophylaxis for Patients with Acute Myeloid Leukemia. Blood 2024, 144: 1480-1480. DOI: 10.1182/blood-2024-211250.Peer-Reviewed Original ResearchInvasive fungal infectionsAcute myeloid leukemiaAntifungal prophylaxisDiagnosed AMLDrug-drug interactionsTransaminase elevationVisual disturbancesRates of invasive fungal infectionsInvasive fungal infections incidenceBaseline ANCCD4 countMyeloid leukemiaAllogeneic stem cell transplantationAnti-fungal prophylaxisAcute myeloid leukemia diagnosisDuration of neutropeniaBaseline CD4 countLess-intensive therapyStem cell transplantationPatient baseline characteristicsSide effect profileCandida sppTriazole agentsWilcoxon rank sum testAntifungal voriconazoleFactors Associated With Surgical Management in Gallbladder Cancer—A Surveillance, Epidemiology, and End Results Medicare–Based Study
Romatoski K, Chung S, Sawhney V, Papageorge M, de Geus S, Ng S, Kenzik K, Tseng J, Sachs T. Factors Associated With Surgical Management in Gallbladder Cancer—A Surveillance, Epidemiology, and End Results Medicare–Based Study. Journal Of Surgical Research 2024, 304: 9-18. PMID: 39481161, DOI: 10.1016/j.jss.2024.09.084.Peer-Reviewed Original ResearchGallbladder cancer patientsGallbladder cancerOncologic resectionStage T1bComplete resectionOverall survivalSurgical oncologistsGeneral surgeonsChi-square and Wilcoxon rank-sum testsOverall survival outcomesNonacademic hospitalsWilcoxon rank sum testRank sum testResection rateSurgical managementSurvival outcomesImproved survivalBaseline characteristicsResectionSEER-MedicarePatient factorsAcademic centersPatientsCCI patientsFrail statusCost Comparison of a Traditional Didactic versus National Flipped Classroom Curriculum
Carbajal M, Karpen H, Arias-Shah A, Gisondo C, French H, Gray M, Izatt S, Gillam-Krakauer M, Johnston L, Payne A, Vasquez M, Bonachea E, Falck A, Chess P, Dadiz R. Cost Comparison of a Traditional Didactic versus National Flipped Classroom Curriculum. American Journal Of Perinatology 2024, 42: 580-585. PMID: 39242091, DOI: 10.1055/a-2410-9126.Peer-Reviewed Original Research117. Opioid prescription patterns following single-level lumbar discectomy: a national database study
Rancu A, Gouzoulis M, Winter A, Katsnelson B, Ansah-Twum J, Grauer J. 117. Opioid prescription patterns following single-level lumbar discectomy: a national database study. The Spine Journal 2024, 24: s60-s61. DOI: 10.1016/j.spinee.2024.06.560.Peer-Reviewed Original ResearchMorphine milligram equivalentsSingle-level lumbar discectomyMedian morphine milligram equivalentsOpioid prescriptionsLumbar discectomyPrescribed morphine milligram equivalentsDiagnosis of chronic painPostoperative opioid prescriptionsOpioid prescribing patternsOpioid prescription patternsPostoperative pain controlPostoperative pain managementProportion of patientsNational database studyMultivariate linear regression analysisWilcoxon rank sum testDiagnosis of neoplasmsMultivariate logistic regressionRank sum testExcess opioidsPrescription percentageMilligram equivalentsPostoperative opioidsChronic painSpine proceduresSerologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis
Thorburn D, Leeming D, Barchuk W, Wang Y, Lu X, Malkov V, Ito K, Bowlus C, Levy C, Goodman Z, Karsdal M, Muir A, Xu J. Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis. Hepatology Communications 2024, 8: e0467. PMID: 38967589, PMCID: PMC11227354, DOI: 10.1097/hc9.0000000000000467.Peer-Reviewed Original ResearchConceptsPrimary sclerosing cholangitisELF scoreAdvanced fibrosisFibrosis stageFibrosis progressionClinical eventsSclerosing cholangitisExtracellular matrix remodeling markersRemodeling markersPredictors of disease severityPhase 2b trialBaseline to weekPRO-C3Progression to cirrhosisWilcoxon rank sum testMarker of collagen formationType III procollagenModerate diagnostic abilityDiagnosing fibrosis stagesRank sum testSerum markersNoninvasive predictorPrognostic markerModerate prognosisMedian changeTBCRC 048 (olaparib expanded) expansion cohorts: Phase 2 study of olaparib monotherapy in patients (pts) with metastatic breast cancer (MBC) with germline (g) mutations in PALB2 or somatic (s) mutations in BRCA1 or BRCA2.
Tung N, Robson M, Nanda R, Li T, Vinayak S, Shah P, Khoury K, Kimmick G, Santa-Maria C, Brufsky A, DeMeo M, Vieira J, Carey L, Wulf G, Domchek S, Krop I, Wolff A, Winer E, Garber J. TBCRC 048 (olaparib expanded) expansion cohorts: Phase 2 study of olaparib monotherapy in patients (pts) with metastatic breast cancer (MBC) with germline (g) mutations in PALB2 or somatic (s) mutations in BRCA1 or BRCA2. Journal Of Clinical Oncology 2024, 42: 1021-1021. DOI: 10.1200/jco.2024.42.16_suppl.1021.Peer-Reviewed Original ResearchProgression-free survivalDuration of responseMetastatic breast cancerClinical benefit rateTriple-negative breast cancerMedian duration of responseMedian progression-free survivalMutant allele frequencyExpansion cohortHER2-negativeHER2-positiveCohort 2aNon-respondersBreast cancerEarly due to slow enrollmentMetastatic chemotherapy regimensResponse to olaparibPhase 2 studyPhase II trialKaplan-Meier methodPredictors of responseCohort of womenWilcoxon rank sum testRank sum testBRCA1m104. Polycystic Ovary Syndrome and Mental Health Co-Morbidities in Adolescents
ONeill N, Lynn A, Zamani M, Kuehne A, Miclette K, Rowe E, Fussner L, Vash-Margita A. 104. Polycystic Ovary Syndrome and Mental Health Co-Morbidities in Adolescents. Journal Of Pediatric And Adolescent Gynecology 2024, 37: 288-289. DOI: 10.1016/j.jpag.2024.01.111.Peer-Reviewed Original ResearchPolycystic ovary syndromeVitD supplementationMental health disordersHormone treatmentCohort studyRetrospective cohort studyYears post-menarcheModified Rotterdam criteriaFisher's exact testTertiary children's hospitalWilcoxon rank sum testEffects of hormonal treatmentAssociated with polycystic ovary syndromeCharacteristics of polycystic ovary syndromeRank sum testGender-affirming treatmentVitD levelsPrevalence of mental health disordersOvarian volumeMental health co-morbiditiesTreatment modalitiesEndocrinology clinicExact testPost-menarcheAnxiety diagnosesMulticenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients.
Ayyagari R, Rahman S, Grizzard K, Mustafa A, Staib L, Makkia R, Bhatia S, Bilhim T, Carnevale F, Davis C, Fischman A, Isaacson A, McClure T, McWilliams J, Nutting C, Richardson A, Salem R, Sapoval M, Yu H. Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients. Radiology 2024, 310: e231877. PMID: 38441098, DOI: 10.1148/radiol.231877.Peer-Reviewed Original ResearchConceptsProstatic artery embolizationCumulative air kermaRadiation-related adverse eventsBody mass indexAdverse eventsEffective doseFluoroscopy timeArtery embolizationRadiation doseKerma area product valuesMedian cumulative air kermaMedian effective radiation doseFluoroscopy unitPatient body mass indexRadiation exposureTwo-sample <i>t</i> test wasRadiation dose dataBenign prostatic hyperplasiaFluoroscopy-guided proceduresPatient radiation exposureEffective radiation doseRadiation field areaRadiation effective doseWilcoxon rank sum testInvasive angiographic proceduresApplication of glutamate weighted CEST in brain imaging of nicotine dependent participants in vivo at 7T
Jacobs P, Jee J, Fang L, Devlin E, Iannelli C, Thakuri D, Loughead J, Epperson C, Wilson N, Roalf D, Reddy R, Nanga R. Application of glutamate weighted CEST in brain imaging of nicotine dependent participants in vivo at 7T. PLOS ONE 2024, 19: e0297310. PMID: 38363747, PMCID: PMC10871471, DOI: 10.1371/journal.pone.0297310.Peer-Reviewed Original ResearchConceptsDorsal anterior cingulate cortexNon-smokersCingulate gyrusAnterior cingulate cortexContext of addictionTreating nicotine addictionApplication of glutamatePopulation of smokersWilcoxon rank sum testGluCEST imagingTraumatic brain injuryT1-weighted imagesInvestigated glutamateSignificant healthcare issueCingulate cortexGray matter regionsRank sum testNicotine useNicotine addictionNicotine dependenceBrain regionsChemical exchange saturation transferNegative age dependenceHealthy participantsUltra-high field MRIDetection of sarcomatoid renal cell carcinoma using plasma cell-free DNA methylation.
Semaan K, El Zarif T, Seo J, Eid M, Canniff J, Fortunato B, Savignano H, Davidsohn M, Lakshminarayanan G, Saad E, Saliby R, Bakouny Z, Matar S, Nuzzo P, Berchuck J, Signoretti S, Braun D, Freedman M, Baca S, Choueiri T. Detection of sarcomatoid renal cell carcinoma using plasma cell-free DNA methylation. Journal Of Clinical Oncology 2024, 42: 449-449. DOI: 10.1200/jco.2024.42.4_suppl.449.Peer-Reviewed Original ResearchDifferentially methylated regionsRenal cell carcinomaCell-free DNAMeDIP-seqSarcomatoid differentiationDNA methylation signalsArea under the receiver operating characteristicHigh-throughput sequencingCell carcinomaCell-free DNA methylationFalse discovery rateResponse to immune checkpoint blockadeEpigenomic approachesCfMeDIP-seqSarcomatoid renal cell carcinomaMethylation immunoprecipitationDNA methylationHistological subtypes of cancerAssociated with poor survivalImmune checkpoint blockadeSubtypes of cancerDana-Farber Cancer InstituteSpatial heterogeneityArea under the receiver operating characteristic curveWilcoxon rank sum test
2023
Hospital Utilization for Patients With Cirrhosis and Severe Ascites in a Model of Outpatient Paracentesis by Interventional Radiology
Ahmed M, Islam M, Gogokhia L, Borz-Baba C, Wakefield D, Jakab S. Hospital Utilization for Patients With Cirrhosis and Severe Ascites in a Model of Outpatient Paracentesis by Interventional Radiology. Cureus 2023, 15: e51397. PMID: 38292997, PMCID: PMC10826452, DOI: 10.7759/cureus.51397.Peer-Reviewed Original ResearchSpontaneous bacterial peritonitisAcute kidney injuryOutpatient paracentesisICU admissionInterventional radiologistsHospital utilizationCirrhosis complicationsKidney injuryHospital admissionClinical outcomesEnd-stage liver diseaseTertiary academic medical centerGastroenterologists/hepatologistsTime of paracentesisAlcohol-related cirrhosisComplications of cirrhosisUpper gastrointestinal bleedingEmergency department visitsEvaluation of patientsCurrent practice guidelinesTransjugular portosystemic shuntModel of careAcademic medical centerWilcoxon rank sum testChi-square testUtility of Hook Sign in the Diagnosis of Median Arcuate Ligament Syndrome
Chan S, Weininger G, Kozhimala M, Sumpio B, Levine L, Harris S, Zheng S, Ochoa Chaar C, Guzman R, Sumpio B. Utility of Hook Sign in the Diagnosis of Median Arcuate Ligament Syndrome. Annals Of Vascular Surgery 2023, 94: 165-171. PMID: 37023920, DOI: 10.1016/j.avsg.2023.03.018.Peer-Reviewed Original ResearchConceptsMedian arcuate ligament syndromeBody mass indexCeliac artery compressionArcuate ligament syndromeCeliac arteryInstitutional review board-approved retrospective chart reviewDiagnosis of MALSElectronic medical record reviewMedian arcuate ligamentNonspecific abdominal painRetrospective chart reviewMedical record reviewTertiary academic centerSignificant predictorsHook signWilcoxon rank sum testRank sum testMALS patientsAbdominal painTomography angiography imagesArtery compressionChart reviewPatient demographicsArcuate ligamentRadiologic characteristicsImpact of acute symptomatic seizures and their management on patient-reported outcomes after stroke
Punia V, Li Y, Lapin B, Chandan P, Newey C, Hantus S, Dhakar M, Rubinos C, Zafar S, Sivaraju A, Katzan I, investigators F. Impact of acute symptomatic seizures and their management on patient-reported outcomes after stroke. Epilepsy & Behavior 2023, 140: 109115. PMID: 36804847, DOI: 10.1016/j.yebeh.2023.109115.Peer-Reviewed Original ResearchConceptsPatient-reported outcome measuresAnti-seizure medicationsAcute symptomatic seizuresOutcome measuresSymptomatic seizuresHospital dischargeASM useExact testFirst patient-reported outcome measureRetrospective cohort studyPatient-reported outcomesStandard of careContinuous EEG monitoringFisher's exact testWilcoxon rank sum testChi-square testRank sum testPROM completionStroke clinicCohort studyRecent strokeStroke patientsNeuro-QoLPhysical functionPatientsDexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)
Ruddy K, Zahrieh D, He J, Waechter B, Holleran J, Lewis L, Chow S, Beumer J, Weiss M, Trikalinos N, Faller B, Lustberg M, Rugo H, Loprinzi C. Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701). Seminars In Oncology 2023, 50: 7-10. PMID: 36693773, PMCID: PMC10247389, DOI: 10.1053/j.seminoncol.2023.01.001.Peer-Reviewed Original ResearchConceptsMTOR inhibitor-associated stomatitisDexamethasone mouthwashCoprimary endpointsTrough concentrationsExact testRandomized phase III trialEverolimus trough concentrationsPrior clinical researchPhase III trialsDose-limiting toxicityFisher's exact testMann-Whitney U testWilcoxon rank sum testRank sum testOral everolimusIII trialsOral stomatitisTreatment periodMouth rinseMTOR inhibitorsPoor enrollmentClinical researchEverolimusU testStomatitis
2022
2348. Distinct cerebrospinal fluid immune proteins mark neurosyphilis
Catalano A, Yoon J, Farhadian S, Fertuzinhos S, Gisslen M, Zetterberg H, Marra C, Walsh H. 2348. Distinct cerebrospinal fluid immune proteins mark neurosyphilis. Open Forum Infectious Diseases 2022, 9: ofac492.155. DOI: 10.1093/ofid/ofac492.155.Peer-Reviewed Original ResearchHIV statusImmune responseBCA-1/CXCL13Macrophage/microglial activationIP-10/CXCL10IL-8/CXCL8CNS immune responseNeuronal injury markersNon-NS groupPotential CSF biomarkersMIG/CXCL9Date of enrollmentHigh-sensitivity ELISAWilcoxon rank sum testSpecific immune pathwaysMultiple comparisonsRank sum testRace/ethnicityCNS inflammationMicroglial activationCSF WBCElevated markersInjury markersNeuronal damageAsymptomatic diseaseMinimal Stimulation Using Gonadotropin-Releasing Hormone Antagonist is Associated with Higher Live Birth Rates: A National Study of 13,050 Cycles
Hurley E, Sun F, Zhang H, Polotsky A, Rios J. Minimal Stimulation Using Gonadotropin-Releasing Hormone Antagonist is Associated with Higher Live Birth Rates: A National Study of 13,050 Cycles. Women's Health Reports 2022, 3: 957-963. PMID: 36479370, PMCID: PMC9712044, DOI: 10.1089/whr.2022.0080.Peer-Reviewed Original ResearchHigher live birth rateLive birth rateGnRH antagonist useAntagonist useMinimal stimulationRank sum testHormone antagonistBirth rateImproved live birth ratesGonadotropin-releasing hormone antagonistCancelation rateCycle cancelation rateGnRH antagonist suppressionMinimal stimulation IVFTotal gonadotropin dosageDiminished ovarian reserveYears of ageWilcoxon rank sum testChi-square testNumber of embryosGonadotropin dosageOvarian reserveGnRH antagonistAntimullerian hormoneOlder women
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply